Antipodes Partners’s Avista AVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64K Sell
1,565
-823
-34% -$33.9K ﹤0.01% 110
2026
Q1
$95.9K Hold
2,388
﹤0.01% 94
2025
Q4
$92K Buy
+2,388
New +$93.3K ﹤0.01% 90

Other funds holding AVA

Antipodes Partners's AVA Position: Q2 2026 in Review

Antipodes Partners reduced its Avista (AVA) stake by 34% in Q2 2026, selling an estimated $33.9K and leaving 1,565 shares worth $64K. The position accounts for ﹤0.01% of the portfolio, ranked #110.

Antipodes Partners first reported a position in AVA in Q4 2025 and has held it in 3 quarters since. The position peaked at $95.9K in Q1 2026. 416 funds tracked by Wall St. Rank hold AVA as of Q2 2026.

  • Antipodes Partners held 1,565 shares of Avista worth $64K as of Q2 2026.
  • Antipodes Partners sold 823 Avista shares in Q2 2026, an estimated $33.9K.
  • Avista made up ﹤0.01% of Antipodes Partners's portfolio in Q2 2026, its #110 holding.
  • Antipodes Partners first reported a position in Avista in Q4 2025 and has held it in 3 quarters since.
  • Antipodes Partners's Avista position peaked at $95.9K in Q1 2026.
  • 416 funds tracked by Wall St. Rank held Avista as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.